Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy

American Journal of Surgery

Volumn 184, Issue 4, 2002, Pages 310-314

  Chung, Maureen A ^a,c   Steinhoff, Margaret M ^b   Cady, Blake ^a  

^a BROWN UNIVERSITY   (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

Breast cancer; Nodal recurrence; Sentinel lymphadenectomy

Indexed keywords

ANTIINFECTIVE AGENT; HORMONE;

ADULT; AGE; AGED; ARTICLE; BREAST CARCINOMA; BREAST SURGERY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPHADENECTOMY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 0036804498     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(02)00956-X     Document Type: Article

References (19)

1. Chung M., Fulton J., Cady B. Trends in breast cancer incidence and presentation in a population screened for breast cancer. Semin Breast Dis. 2:1999;55-63.
2. Chung M.A., Wazer D., Cady B. Diagnosis and contemporary management of breast cancer. Obstet Gynecol Clin North Am. 29:2002;173-188.
3. Giuliano A.E., Kirgan D.M., Guenther J.F., Moron D.C. Lmphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 220:1999;391-398.
4. Lucci A., Kelemen P.R., Miller C., et al. National practice patterns of sentinel lymph node dissection for breast carcinoma. J Am Coll Surg. 192:2001;453-458.
5. Harlow S.P., Krag D.N. Sentinel lymph node - why study it implications of the B-32 study. Semin Surg Oncol. 20:2001;224-229.
6. Ross M.I. Sentinel node dissection in early-stage breast cancer ongoing prospective randomized trials in the USA. Ann Surg Oncol. 8:2001;77S-81S.
7. Miltenburg D.M., Miller C., Karamlou T.B., Brunicardi F.C. Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res. 84:1999;138-142.
8. Chua B., Ung O., Boyages J. Competing considerations in regional nodal treatment for early breast cancer. Breast J. 8:2002;15-22.
9. Newman L.A., Hunt K.K., Cuchholz T., et al. Presentation, management and outcome of axillary recurrence from breast cancer. Am J Surg. 180:2000;252-256.
10. Zgajnar J., Gatzemeier W., Costa A. Will the sentinel lymph node (SLN) stand a second time - SLN biopsy in breast cancer patients with isolated local recurrence following breast conserving therapy and previous SLN procedure. Ann Oncol. 12:2001;723.
11. Schrenk P., Hatzl-Griesenhodfer M., Shamiyeh A., Waynad W. Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol. 77:2001;165-170.
12. Roumen R.M., Kuijt G.P., Liem I.H., van Beek M.W. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg. 88:2001;1639-1643.
13. Giuliana A.E., Haigh P.I., Brennan M.P., et al. Prospective observational study of sentinel lymphadenectomy without furthre axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol. 18:2000;2553-2559.
14. Veronesi U., Galimberti V., Zurrida S., et al. Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer. 37:2001;454-458.
15. Clary B.M., Mann B., Brady M.S., et al. Early recurrence after lymphatic mapping and sentinel node biopsy in patients with extremity melanoma a comparison with elective lymph node dissection. Ann Surg Oncol. 8:2001;328-337.
16. Statius Muller M.G., Borgstein P.J., Pijpers R., et al. Reliability of the sentinel node procedure in melanoma patients analysis of failures after long-term follow-up. Ann Surg Oncol. 7:2000;461-468.
17. Gadd M., Cpsimi A., Yu J., et al. Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg. 134:1999;381-387.
18. Essner R., Conforti A., Kelley M., et al. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol. 6:1999;441-449.
19. Gershenwald J., Colome M., Lee J., et al. Patterns of recurrence following a negative sentinel lymph node biopsy with stage I or II melanoma. J Clin Oncol. 1998;2253-2260.